Tenax Therapeutics TENX 深 滬
已收盤 07-31 16:00:00 美东时间
13.70
-1.400
-9.27%
華盛通- 最 高15.52
- 今 開15.04
- 成交量 178.43万股
- 最 低 13.65
- 昨 收 15.10
- 總市值 3.63亿
- 52周最高 19.40
- 市盈率 靜 --
- 換手率 6.73%
- 52周最低 5.78
- 委 比 50.00%
- 總股本 2652.52万
- 歷史最高 274560.00
- 量 比 1.11
- 振 幅 12.38%
- 歷史最低 4.63
- 每 手 1
- 風險率 3.42%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Tenax Therapeutics Q2 EPS $(0.35) Beats $(0.37) Estimate
Tenax Therapeutics (NASDAQ:TENX) reported quarterly losses of $(0.35) per share which beat the analyst consensus estimate of $(0.37) by 5.41 percent. This is a 29.63 percent decrease over losses of $(0.27) per share from the same period last year.
07-31 19:30
美股大行评级 | 潜在涨幅129.15%！HC Wainwright & Co.升Q32 Bio(QTTB)目标价至36美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Q32 Bio"买入"评级，目标价从13美元升至36美元；Chardan Capital：维持ProMIS Neurosciences"买入"评级，目标价从20美元升至33美元
07-29 11:37
美股大行评级 | 富国银行上调闪迪目标价从1250美元升至1620美元；最高132美元！高盛、大小摩等多家机构上调通用汽车目标价
今日重点评级关注：HC Wainwright & Co.：维持IREN"买入"评级，目标价从85美元升至90美元；BTIG：维持FTAI Aviation"买入"评级，目标价从340美元升至400美元
07-23 13:42
Evercore ISI Group Initiates Coverage On Tenax Therapeutics with Outperform Rating, Announces Price Target of $39
Evercore ISI Group analyst Gavin Clark-Gartner initiates coverage on Tenax Therapeutics (NASDAQ:TENX) with a Outperform rating and announces Price Target of $39.
07-22 22:59
Tenax Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
<p>Tenax Therapeutics, Inc. awarded inducement option awards to three newly hired non-executive employees on July 1, 2026, as material inducements to their employment. The employees received non-qualified stock options to purchase 160,000 shares of the Company's common stock, with 25% vesting on the first anniversary of the grant date and the remaining shares vesting in 36 equal monthly installments. The awards were approved by the Board's Compen...
07-02 20:05
Tenax Therapeutics To Present Results From Phase 3 LEVEL Clinical Trial In Late-Breaking Clinical Science Session At ESC Congress 2026
Abstract recently submitted in anticipation of initial data analysis ahead of ESC Company expects to report topline LEVEL results in August CHAPEL HILL, N.C., July 02, 2026 (GLOBE NEWSWIRE) -- Tenax Therapeutics, Inc. (NASDAQ:TENX) ("Tenax" or "Tenax Therapeutics" or the "Company") announced today t...
07-02 19:03
Tenax Therapeutics Announces Late-Breaking Presentation of LEVEL Clinical Trial Data at ESC Congress 2026
Tenax Therapeutics announced that results from its Phase 3 LEVEL clinical trial will be presented at the ESC Congress 2026 in Munich. The Company expects to report topline data in August, with the presentation scheduled for August 29. The trial evaluates TNX-103 for treating pulmonary hypertension in heart failure with preserved ejection fraction (PH-HFpEF), a condition lacking approved treatments. Enrollment of over 230 patients was completed in...
07-02 11:00
Tenax Therapeutics Updates Executive and Employee Severance Protections
The latest announcement is out from Tenax Therapeutics ( ($TENX) ). On June 26,...
06-30 04:59
美股大行评级 | 瑞银上调超微公司目标价从455美元升至670美元，上调ARM目标价从260美元升至470美元；美银证券上调台积电目标价从490美元升至590美元
今日重点评级关注：Jones Trading：维持Definium Therapeutics"买入"评级，目标价从61美元升至74美元；韦德布什：维持Cerebras Systems"跑赢大市"评级，目标价从270美元升至280美元
06-25 11:32
美股大行评级 | 阿斯麦获美银、富国上调目标价最高至2345美元；Needham上调美光科技目标价从500美元升至1550美元
今日重点评级关注：Baird：维持Regenxbio"跑赢大市"评级，目标价从27美元升至32美元；古根海姆：维持Tenax Therapeutics"买入"评级，目标价从34美元升至40美元
06-23 13:48
